Skip to main content

Master of Public Health

Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline

AUTHORS

Newman C , Blaha MJ , Boord JB , Cariou B , Chait A , Fein H , Ginsberg H , Goldberg I , Murad MH , Subramanian S , Tannock LR , . The Journal of clinical endocrinology and metabolism. 2020 9 19; ().

ABSTRACT

OBJECTIVE: This guideline will provide the practicing endocrinologist with an approach to assessment and treatment of dyslipidemia in patients with endocrine diseases, with the objective of prevention of cardiovascular events and triglyceride-induced pancreatitis. The guideline reviews data on dyslipidemia and ASCVD risk in patients with endocrine disorders and discusses the evidence for correction of dyslipidemia by treatment of the endocrine disease. The guideline also addresses whether treatment of the endocrine disease reduces ASCVD risk.

CONCLUSION: This guideline focuses on lipid and lipoprotein abnormalities associated with endocrine diseases, including diabetes mellitus, and whether treatment of the endocrine disorder improves not only the lipid abnormalities, but also cardiovascular outcomes. Based on the available evidence, recommendations are made for the assessment and management of dyslipidemia in patients with endocrine diseases.

Tags: